NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug help heart muscle disease? large trial underway
Symptom relief Recruiting nowThis Phase 3 study tests whether the drug sotagliflozin can improve symptoms and daily function in 500 adults with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. Participants take either the drug or a placebo pill once daily for 26 weeks. The main…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New drug aims to ease symptoms of stiff heart muscle
Symptom relief Recruiting nowThis study tests a drug called ninerafaxstat in people with a type of heart muscle disease that makes the heart stiff and causes symptoms like shortness of breath and fatigue. The trial involves 165 participants who will receive either the drug or a placebo. The main goal is to s…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC